Daewoong Co., Ltd 3
3 · AEON Biopharma, Inc. · Filed Jul 28, 2023
Insider Transaction Report
Form 3
Daewoong Co., Ltd
10% Owner
Holdings
- 2,400,000(indirect: Indirect Beneficial Ownership in the 2,400,000 owned by Daewoong Pharmaceutical Co., Ltd)
Common Stock, $0.0001 par value per share
- 4,177,604
Common Stock, $0.0001 par value per share
Footnotes (1)
- [F1]Daewoong Co., Ltd., a company organized under the laws of the Republic of Korea, owns 51% of the outstanding shares of Daewoong Pharmaceutical Co., Ltd., a company organized under the laws of the Republic of Korea; Daewoong Co., Ltd. has voting power and dispositive power over Daewoong Pharmaceutical Co., Ltd. and therefore may be deemed to indirectly own such shares.